Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

Conditions:   Multiple Myeloma;   Effects of Chemotherapy Intervention:   Drug: Bortezomib, cyclophosphamide, thalidomide, dexamethasone Sponsor:   Grupo de Estudos Multicentricos em Onco-Hematologia Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials